Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney
Context: There is a need to define the exact benefits and contraindications of use of high-dose recombinant human erythropoietin (EPO) for its non-hematopoietic function as a cytokine that enhances tissue repair after injury. This review compares the outcomes from use of EPO in the injured heart and...
Saved in:
Main Authors: | Glenda C Gobe (Author), Christudas Morais (Author), David A Vesey (Author), David W Johnson (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2013-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu
by: David A. Vesey, et al.
Published: (2024) -
Obesity may be erythropoietin dose-saving in hemodialysis patients
by: Ghada M. El-Kannishy, et al.
Published: (2018) -
Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model
by: Gail D Anderson, et al.
Published: (2013) -
Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
by: Christian Klopsch, et al.
Published: (2018) -
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
by: Henry H.L. Wu, et al.
Published: (2022)